Atlas Trials

A Efficacy and Safety Trial of Controlled Release (CR) Morphine in Cancer Patients

Clinical trial NCT00446069 · COMPLETED

Trial details

NCT number
NCT00446069
Sponsor
Egalet Ltd
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
PainCancer
Start date
2007-08-01
Primary completion
2008-06-01
Enrollment
36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.